SCHEMBL19126162

SCHEMBL19126162

C[SH](C)(C)(C)C#Cc1cccc(Nc2ncnc3cc(OCCOC(F)F)c(NC(=O)/C=C/CBr)cc23)c1F

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.49
▸ ERBB2 P04626 7/20 0.49
▸ KDR P35968 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19100043 0.91 EGFR (0.49) EGFRERBB2KDR
SCHEMBL20653209 0.91 EGFR (0.48) EGFRERBB2KDR
SCHEMBL19100256 0.87 EGFR (0.58) EGFRERBB2KDR
SCHEMBL19100047 0.83 EGFR (0.58) EGFRERBB2KDR
SCHEMBL19125881 0.83 EGFR (0.58) EGFRERBB2KDR
SCHEMBL19100267 0.83 EGFR (0.61) EGFRERBB2KDR
SCHEMBL20653216 0.83 EGFR (0.58) EGFRERBB2KDR
SCHEMBL19100065 0.82 EGFR (0.64) EGFRERBB2KDR
SCHEMBL19100193 0.80 EGFR (0.68) EGFRERBB2KDR
SCHEMBL19124461 0.79 EGFR (0.63) EGFRERBB2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017117680-A1 NOVEL FLUORINATED QUINAZOLINE DERIVATIVES AS EGFR INHIBITORS TRILLIUM THERAPEUTICS INC. (CA) 2017-07-13 — — WO disclosed
Send feedback